Company
Inventiva S.A. (IVA)
Standardized SEC financial data for Inventiva S.A. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001756594 · NASDAQ · Pharmaceutical Preparations.
Net margin
-1000.0%
Revenue growth (YoY)
-47.4%
Return on equity
172.7%
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| € | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | €7.0M | €372K | €4.2M | €12.2M | €17.5M | €9.2M |
| R&D expense | €33.8M |
Standardized from Inventiva S.A.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| € | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total assets | €57.0M | €138.9M | €122.0M | €116.0M | €69.6M | €119.0M |
| Total liabilities |
Get IVA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/IVA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/IVA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"